share_log

8-K: Current report

8-K: Current report

8-K:重大事件
美股SEC公告 ·  10/29 16:19

Moomoo AI 已提取核心信息

180 Life Sciences Corp. has announced that its 2024 Annual Meeting of Shareholders is scheduled for December 27, 2024. The Board of Directors set the date on October 29, 2024, and noted that the specific time and location details will be included in the definitive proxy statement to be filed with the SEC. Shareholders on record as of October 31, 2024, will be eligible to receive notice and vote at the meeting. The company also outlined the deadline for shareholder proposals and director nominations, which must be received by November 8, 2024, to be considered for inclusion in the proxy materials. Proposals must comply with SEC rules, Delaware law, and the company's bylaws. The announcement was made in a Form 8-K filed with the SEC by Interim CEO Blair Jordan on October 29, 2024.
180 Life Sciences Corp. has announced that its 2024 Annual Meeting of Shareholders is scheduled for December 27, 2024. The Board of Directors set the date on October 29, 2024, and noted that the specific time and location details will be included in the definitive proxy statement to be filed with the SEC. Shareholders on record as of October 31, 2024, will be eligible to receive notice and vote at the meeting. The company also outlined the deadline for shareholder proposals and director nominations, which must be received by November 8, 2024, to be considered for inclusion in the proxy materials. Proposals must comply with SEC rules, Delaware law, and the company's bylaws. The announcement was made in a Form 8-K filed with the SEC by Interim CEO Blair Jordan on October 29, 2024.
180 Life Sciences Corp.宣布,其2024年股东大会定于2024年12月27日举行。董事会于2024年10月29日设定了日期,并指出具体时间和地点将包含在将提交给SEC的决议代理声明中。截至2024年10月31日股东记录日的股东将有资格收到通知并在会议上投票。公司还概述了股东提案和董事提名的截止日期,必须在2024年11月8日前收到,才能被视为纳入代理材料。提案必须遵守SEC规则、特拉华州法律和公司章程。这一公告是由临时CEO Blair Jordan于2024年10月29日在提交给SEC的8-k表格中发布的。
180 Life Sciences Corp.宣布,其2024年股东大会定于2024年12月27日举行。董事会于2024年10月29日设定了日期,并指出具体时间和地点将包含在将提交给SEC的决议代理声明中。截至2024年10月31日股东记录日的股东将有资格收到通知并在会议上投票。公司还概述了股东提案和董事提名的截止日期,必须在2024年11月8日前收到,才能被视为纳入代理材料。提案必须遵守SEC规则、特拉华州法律和公司章程。这一公告是由临时CEO Blair Jordan于2024年10月29日在提交给SEC的8-k表格中发布的。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息